Tencent-backed healthcare firm WeDoctor Group, Hong Kong-listed financial services company Mason Group and Asian investment firm Aldworth Management will reportedly team up to acquire Australian fertility treatment firm Genea for an estimated HKD4 billion (about US$509 million), according to media reports. The consortium made an offer ranging from HKD3.4 billion to HKD4 billion (approximately US$433 million to US$509 million), according to Chinese local media. Another Australian media report said the consortium is trying to acquire 89.5% stake in Genea. WeDoctor, Mason Group, Aldworth Management and Genea did …

Hong Kong-Based Consortium Reportedly To Buy Australian Fertility Treatment Provider For US$509M appeared first on China Money Network.


Visit the original source and full text: China Money Network